T1	Participants 156 191	glucocorticoid-induced osteoporosis
T2	Participants 330 366	glucocorticoid-induced osteoporosis.
T3	Participants 580 608	patients on glucocorticoids,
T4	Participants 869 877	Patients
T5	Participants 1083 1293	subgrouped by age; gender; menopausal status in women; dose and duration of prednisone during the trial; and baseline serum 25-OH vitamin D, LS BMD T-score, creatinine clearance, and concomitant medication use.
T6	Participants 1874 1895	Osteoporotic patients